CCR2 and neoplasm: Instead, Ly6Chi CCR2+ monocytes are known to give rise to the majority of tumor-associated macrophages (22–24) and contribute to the pool of monocytic myeloid-derived suppressor cells (MDSCs) that promote tumor growth and suppress antitumor immunity (25, 26).